Novavax, Inc. (NVAX) vs Xencor, Inc. (XNCR)
Novavax, Inc. and Xencor, Inc. are both Biotechnology companies. Novavax, Inc. and Xencor, Inc. are of similar size ($1.8B and $1.8B). Xencor, Inc. grew revenue faster over the last twelve months: −28.6% against −61.6%. Novavax, Inc. has the higher net margin (−59.9% vs −155.6%) and the higher return on invested capital (0.00% vs −288.7%). Across the 17 metrics below, Novavax, Inc. leads on 12 and Xencor, Inc. on 5.
Valuation
Profitability
| Metric | NVAX | XNCR | Biotechnology median |
|---|---|---|---|
| Gross margin | 78.60% | 100.00% | 65.16% |
| Operating margin | (56.58%) | (205.84%) | 0.00% |
| Net margin | (59.87%) | (155.59%) | 0.00% |
| Free cash flow margin | (10.20%) | (198.42%) | 0.00% |
| Return on equity | 323.66% | (29.07%) | (57.72%) |
| Return on assets | (21.62%) | (20.36%) | (49.22%) |
| Return on invested capital | 0.00% | (288.71%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack